Cargando…
[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
Since hyperactivity of the protein kinase DYRK1A is linked to several neurodegenerative disorders, DYRK1A inhibitors have been suggested as potential therapeutics for Down syndrome and Alzheimer’s disease. Most published inhibitors to date suffer from low selectivity against related kinases or from...
Autores principales: | Lechner, Christian, Flaßhoff, Maren, Falke, Hannes, Preu, Lutz, Loaëc, Nadége, Meijer, Laurent, Knapp, Stefan, Chaikuad, Apirat, Kunick, Conrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891749/ https://www.ncbi.nlm.nih.gov/pubmed/31766108 http://dx.doi.org/10.3390/molecules24224090 |
Ejemplares similares
-
Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
por: Meine, Rosanna, et al.
Publicado: (2018) -
10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic
Acids Are Selective Inhibitors
of DYRK1A
por: Falke, Hannes, et al.
Publicado: (2015) -
Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
por: Walter, Anne, et al.
Publicado: (2018) -
Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022) -
A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome–associated kinase Dyrk1A overexpression
por: Buchberger, Astrid, et al.
Publicado: (2021)